Cohance Lifesciences Ltd
NSE: COHANCE BSE: 543064
₹311.95
(3.48%)
Mon, 06 Apr 2026, 00:27 pm
Market Cap115.5B
PE Ratio54.25
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KCohance Lifesciences Income Statement
| Particulars | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total revenue | 3.70B | 8.17B | 9.95B | 13.07B | 13.31B | 10.36B | 11.80B |
| Gross profit | 1.74B | 3.96B | 4.52B | 5.95B | 5.87B | 4.38B | 4.39B |
| Operating expenses (excl. COGS) | -186.20M | -463.83M | -422.85M | -500.54M | -513.69M | -877.50M | -1.17B |
| Selling/general/admin expenses, total | -191.69M | -481.08M | -486.56M | -590.15M | -601.28M | -869.60M | -1.14B |
| Research & development | — | -141.31M | -110.58M | -103.55M | -85.86M | -111.20M | -158.80M |
| Selling/general/admin expenses, other | -191.69M | -339.76M | -375.98M | -486.61M | -515.42M | -758.40M | -983.70M |
| Other operating expenses, total | 5.49M | 17.25M | 63.70M | 89.61M | 87.59M | -7.90M | -29.80M |
| Operating income | 1.55B | 3.49B | 4.10B | 5.45B | 5.36B | 3.50B | 3.22B |
| Non-operating income, total | 25.46M | 70.50M | 43.60M | 813.94M | 236.54M | 554.40M | 220.10M |
| Interest expense, net of interest capitalized | -27.89M | -203.22M | -114.06M | -84.31M | -127.98M | -74.50M | -123.50M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 50.96M | 272.23M | 157.66M | 894.51M | 363.36M | 626.20M | 309.30M |
| Non-operating interest income | 1.98M | 3.61M | 2.68M | 686.00K | 58.32M | 19.30M | 12.70M |
| Miscellaneous non-operating expense | 48.98M | 268.62M | 154.98M | 893.83M | 305.04M | 606.90M | 296.60M |
| Unusual income/expense | 2.39M | 1.50M | 0 | 3.74M | 1.17M | 2.70M | 34.30M |
| Pretax income | 1.58B | 3.56B | 4.14B | 6.26B | 5.60B | 4.06B | 3.44B |
| Taxes | -485.93M | -875.10M | -1.05B | -2.14B | -1.48B | -1.05B | -791.50M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 31.00M |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 1.09B | 3.17B | 3.62B | 4.54B | 4.11B | 3.00B | 2.68B |
| Net income | 1.09B | 3.17B | 3.62B | 4.54B | 4.11B | 3.00B | 2.68B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 1.09B | 3.17B | 3.62B | 4.54B | 4.11B | 3.00B | 2.68B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - |
| EBITDA | 1.67B | 3.73B | 4.41B | 5.84B | 5.84B | 4.05B | 3.99B |
| EBIT | 1.55B | 3.49B | 4.10B | 5.45B | 5.36B | 3.50B | 3.22B |
| Total operating expenses | -2.14B | -4.68B | -5.86B | -7.62B | -7.95B | -6.86B | -8.58B |
| Prepaid expenses | 38.60M | 38.59M | 43.97M | 64.00M | 86.28M | 49.20M | 104.40M |
| Deferred income, current | 39.91M | 12.02M | 72.00K | 38.00M | 8.08M | 6.90M | 21.60M |
| Capital and operating lease obligations | 0 | 7.39M | 7.39M | 4.63M | 7.00M | 1.69B | 1.69B |
| Operating lease liabilities | — | — | — | — | — | — | — |
| Deferred tax liabilities | 291.72M | 295.41M | 334.00M | 557.90M | 596.36M | 656.00M | 909.80M |
| Deferred income, non-current | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 1.44B |
| Change in accrued expenses | — | — | — | — | — | — | — |
| Common dividends paid | -230.17M | -767.23M | -254.56M | -1.02B | -2.04B | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800